Navigation Links
Early therapy aids eyesight

Early therapy for early outset glaucoma appears to slow the advancement of the disease. Researchers report immediate treatment of the most common form of glaucoma appears to impact the progression of vision loss.// This has very few significant signs. Doctors are able to detect it only in a detailed eye exam. In this study, doctors recruited 202 patients who had early stage glaucoma in one eye. Around half of the group was treated with medicine and laser to reduce the amount of internal pressure in the eye. The rest of the group was left untreated. Patients who later showed signs of developing the disease were offered treatment.

Six years into the study, doctors found the disease progressed more slowly in the treated patients than in the untreated patients. In the treated patients, eye pressure was lowered by about 25 percent. Many patients showed no disease progression during the study. However, researchers are concerned that as many as 20 percent of treated patients went on to develop glaucoma. The lead author of the study, Anders Heijl, M.D., Ph.D., suspects glaucoma progresses at different speeds in patients and those with an aggressive form of the disease were not helped much by treatment.

The most common form of glaucoma affects nearly 1.0 million people over age 45. While doctors find treating eye pressure may help slow the disease, they do not believe elevated eye pressure necessarily is the cause of the disease. Further research will be done to continue to understand the cause.


'"/>




Page: 1

Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants
11. Early Detection Of Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Early therapy aids eyesight

(Date:11/25/2009)...entinelleMedicalInc.,aleadingmanufacturerofMagneti...ientificInc.,aleadingproviderofsoftwareenablingtec...st4DAdvancedVisualizationsoftware. ,, Thisinnov...ntbasedmedicalimagingofferinginthemarket.CalgarySc...ntaccess-requiringnosoftwaredownload,andrunsonanyM...
(Date:11/25/2009)...ewswire/--AnarticlebyJanetWoodcock,M.D.,directorof...ADifficultBalance-PainManagement,DrugSafety,andthe...urnalofMedicine. ,, (Logo: http://www.newscom.c...cle,WoodcockdiscussesFDAeffortstostrikeabalancebet...gingtherisksposedbyvariousanalgesics.Asexamples,sh...
(Date:11/25/2009)...ndPressJoinEfforttoEducate ,, MEMPHIS,Tenn.,No...BipolarFoundationandtheMedicAlertFoundationreceive...,whichisnowbeingwidelyacceptedasapreventivehealthc...larFoundationreceivedaproclamationofendorsementvia...sianaMitchLandrieu.TheNationalBipolarFoundationsta...
(Date:11/25/2009)...collaboration between UCLA engineers and physician...llion Americans who suffer from peripheral arteria...arteries, peripheral arterial disease, or PAD, is ...eries reduce blood flow to the limbs. The conditio...eart attack and stroke, and its progression can re...
(Date:11/25/2009)...thritis, could help newly diagnosed diabetics, stu...ay News) -- A drug commonly used to treat non-Hodg...hows some promise in helping patients newly diagno... (Rituxan), helped patients keep producing some of...stroyed some of their pancreatic beta cells, which...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...largest ever Parkinson's disease (PD) clinical tri...eatine can slow the symptom progression of this di...he brain in which patients develop tremor, slownes...ask the symptoms but none to slow their progressio...
...portionately higher rates of chronic disease than ...ty Department of Public Health in conjunction wit...mes reports. The report, which examined th...by telephone in 2005. According to the report, wom...
...he way of administering the one effective drug, th... deaths in the USA, reports say . Stroke i..., behind heart disease and cancer, killing 150,000... But from diagnosis to treatment to rehabilitation...
...es, too. Together, they form a difficult pair to b...of Ohio University College of Osteopathic Medicine... together a new approach to the double-edged probl... a combination of exercise and talk therapy as a t...
...n the computer can lead to a condition known as Re...ouse arm, warn experts . "Tingling, numbne...e first signs of overstressing of the tendons and ... computer mouse and an unnatural hand position cau...
...nd inter-tribal tensions. The cultural bias agains... terribly exhausting, almost fruitless, yet anoth...tinuing, extraordinary HIV prevalence in Botswana ...ans for Human Rights (PHR) said. "The impact ...
Other Medicine News:Health News:Emory Participates in Study to Slow Progression of Parkinson's Disease 2Health News:Minority Women in LA County Have Higher Rates of Chronic Disease Than Whites 2Health News:Lack of Timely Intervention Results in Needless Death Due to Stroke in US 2Health News:Study Tests Depression Treatment for Diabetes Patients 2Health News:Study Tests Depression Treatment for Diabetes Patients 3Health News:Cultural Bias Against Women Hampering Fight Against AIDS in Africa 2
(Date:11/25/2009)...ewswire/--RegadoBiosciences,aprivatelyheldcompanyl...tivecontrolagents,announcedthatDavidMazzo,PhD,CEOa...nnualHealthCareConferenceattheNewYorkPalaceHotelin...0pm(EST)onTuesday,December1andwillincludeanovervie...pmentprogram,theanticoagulantsystem,REG1.Thehealth...
(Date:11/25/2009)...wswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amed...analysissystems,announcedtodaythatClintSeverson,ch...tAnnualPiperJaffrayHealthCareConferenceonWednesday...dattheNewYorkPalaceHotelinNewYorkCity. ,, Abou...tsportablebloodanalysissystemsforuseinanyveterinar...
(Date:11/25/2009)...swire/--CempraPharmaceuticalsInc.todayannouncedtha...ficer,willpresentatthePiperJaffray21stAnnualHealth...wYorkPalaceHotelinNewYorkCity.Dr.Fernandeswillprov...nicalprogramsforthetreatmentofdrug-resistantpathog...s ,, Foundedin2006,CempraPharmaceuticalsisapri...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Repair ACL Injuries in Young Athletes Quickly 51663 1Repair ACL Injuries in Young Athletes Quickly 51663 2K State scientist receives grant from National Institutes of Health to research cataracts 51658 1K State scientist receives grant from National Institutes of Health to research cataracts 51658 2Smaller plants punch above their weight in the forest say Queens biologists 9259 1Smaller plants punch above their weight in the forest say Queens biologists 9259 2
..., a bioMerieux company,that discovers, develops an...,oncology, reported today findings from three stud...say to predict risk of disease recurrence in,indiv...ed this week at the San,Antonio Breast Cancer Symp...dex(SM) (BCI) is a combination of Theros,H/I(SM) (...
...ta from two early,clinical studies show that RAD00...ptin(R) (trastuzumab)* in women with HER2-positive...he initiation of a Phase III clinical trial,progra...ed brand name,Afinitor(R)) in breast cancer. , ... the CTRC-AACR San Antonio,Breast Cancer Symposium...
Other Medicine Technology:Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium 2Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium 3Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium 4RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 2RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 3RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 4RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 5RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 6RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 7
USA Elite System™ Visual Urethrotome
USA Elite System™ Visual Urethrotome Kit
Classic Series™ Otis Urethrotome
...-2000 Flexible Cystoscope with Slide-On EndoSheath...ue and efficient solution for Urologists in both t...conventional flexible cystoscopes, which require r...-2000 eliminates the need to reprocess between eve...
Medicine Products: